July 23, 2019
Recently, we had the opportunity to interview Professor George Church, a well-known geneticist and rejuvenation expert. Prof. Church's company, Rejuvenate Bio, will be launching a clinical trial to test a rejuvenation therapy in dogs this fall. In your recent paper on enabling large-scale genome editing, you talked about manipulating endogenous transposable elements with the help...
July 22, 2019
Today, we want to highlight a recent human trial of the popular supplement nicotinamide riboside, a compound that has been shown in mice to restore NAD+ levels. The compound has had impressive results against some aspects of aging in mouse studies, and there is now some more data for NR in humans [1]. What is...
July 17, 2019
The internet is rife with myths and articles making dubious claims about certain foods and their anti-cancer properties. We have all seen the articles of questionable scientific merit gracing social media suggesting that such-and-such foods can cure cancer, the majority of which are highly questionable. A new study offers a unique kind of insight into...
July 15, 2019
Our Ending Age-Related Diseases conference in New York is over for this year and has been a huge success. We had the opportunity to interview one of the speakers, Dr. María Blasco, during the conference, and we asked her more about her work with telomeres, telomerase therapy, and aging. Telomere loss is a proposed reason...
July 09, 2019
The Lifespan Extension Advocacy Foundation, a nonprofit organization dedicated to promoting healthy longevity and aging research through crowdfunding and advocacy initiatives, is hosting its second annual scientific conference, Ending Age-Related Diseases: Investment Prospects and Advances in Research, at the Cooper Union in New York City on July 11th-12th. The goal of this conference is to...
July 08, 2019
There are now only two days to go before the Ending Age-Related Diseases 2019 conference at the Cooper Union in New York City. This is our annual conference that brings together industry leaders from biotech research and business. We have almost sold out of tickets, so if you are thinking about attending, you should act...
